The FDA approves Mylan’s (MYL -3.6%) Semglee (insulin glargine injection) for glycemic control in adults with type 1 or type 2 diabetes.
The product will be available in a multidose vial and single-use prefilled pen.
https://seekingalpha.com/news/3582372-fda-oks-mylan-long-acting-insulin
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.